Raj Dua
Directeur/Bestuurslid bij Abacus Bioscience, Inc.
Profiel
Raj Dua is currently working as a Director at Abacus Bioscience, Inc. and as a Chemistry, Manufacturing & Controls Manager at Resolve Therapeutics LLC.
Previously, he worked as a Director-Assay Development & Process Validation at Xcyte Therapies, Inc., a Senior Director-Product Development at Emergent Product Development Seattle, and a Vice President-Pharmaceutical Operations at Lundbeck Seattle BioPharmaceuticals, Inc. Dr. Dua holds an MBA degree from the University of Washington and a doctorate degree from the University of Georgia.
Actieve functies van Raj Dua
| Bedrijven | Functie | Begin |
|---|---|---|
Resolve Therapeutics LLC
 Resolve Therapeutics LLC BiotechnologyHealth Technology Resolve Therapeutics LLC operates as a biotechnology company. It engages in the development of biotechnology drugs. The firm specializes in treatment of debilitating autoimmune diseases such as Systemic Lupus Erythematous and Sjogren’s syndrome. The company was founded by James Posada in 2010 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Abacus Bioscience, Inc.
 Abacus Bioscience, Inc. BiotechnologyHealth Technology Abacus Bioscience, Inc. develops developing novel immunotherapeutic treatments for cancer and antiviral diseases. The company was founded by Edward A Clark and Craig W Philips and is headquartered in Seattle, WA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Raj Dua
| Bedrijven | Functie | Einde |
|---|---|---|
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
| Xcyte Therapies, Inc. | Corporate Officer/Principal | - |
| ALDER BIOPHARMACEUTICALS, INC. | Operationeel Directeur | - |
Opleiding van Raj Dua
| University of Georgia | Doctorate Degree |
| University of Washington | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
| Xcyte Therapies, Inc. | Health Technology |
Resolve Therapeutics LLC
Resolve Therapeutics LLC BiotechnologyHealth Technology Resolve Therapeutics LLC operates as a biotechnology company. It engages in the development of biotechnology drugs. The firm specializes in treatment of debilitating autoimmune diseases such as Systemic Lupus Erythematous and Sjogren’s syndrome. The company was founded by James Posada in 2010 and is headquartered in Seattle, WA. | Health Technology |
Abacus Bioscience, Inc.
Abacus Bioscience, Inc. BiotechnologyHealth Technology Abacus Bioscience, Inc. develops developing novel immunotherapeutic treatments for cancer and antiviral diseases. The company was founded by Edward A Clark and Craig W Philips and is headquartered in Seattle, WA. | Health Technology |
